Señales en vivo de TOL.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 11:10):

Stats
Volumen de hoy	143 056
Volumen promedio	160 078
Capitalización de mercado	116.93M
EPS	SEK-0.00963 ( 2023-09-30 )
Próxima fecha de ganancias	( SEK0 ) 2024-06-06
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-13.25
ATR14	SEK0.0110 (2.08%)

Toleranzia AB Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Toleranzia AB Finanzas

Annual	2023
Ingresos:	SEK51.27M
Beneficio Bruto:	SEK51.24M (99.95 %)
EPS:	SEK-0.0560

FY	2023
Ingresos:	SEK51.27M
Beneficio Bruto:	SEK51.24M (99.95 %)
EPS:	SEK-0.0560

FY	2022
Ingresos:	SEK35.37M
Beneficio Bruto:	SEK70.62M (199.69 %)
EPS:	SEK-0.0767

FY	2021
Ingresos:	SEK0.00
Beneficio Bruto:	SEK27.12M (0.00 %)
EPS:	SEK-0.0596

Financial Reports:

No articles found.

Toleranzia AB

Toleranzia AB, a biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases. The company is primarily developing TOL2 drug candidate for treating myasthenia gravis, an autoimmune nerve and muscle disease. It also intends to develop TOL3 drug candidate to treat ANCA vasculitis, an autoimmune blood vessel disease. In addition, the company develops tolerogens technology, a treatment method that creates disease-specific tolerance in the immune system for treating various autoimmune diseases. The company was founded in 2011 and is headquartered in Gothenburg, Sweden.